脑微出血:影像学与临床意义
脑微出血(CMBs)在MR T2*加权或磁敏感加权成像上表现为低信号灶,反映血管病所致含铁血黄素沉积;1.5T或3.0T结合T2*或SW成像的真阳性率为48%-89%,假阳性率11%-24%,尸检对照示生前临床MR至少漏诊半数CMBs;CMBs随场强和三维序列应用更常被检出,见于正常老化及阿尔茨海默痴呆、脑淀粉样血管病、卒中和创伤等,卒中患者合并CMBs提示预后更差。
要点
- CMBs在T2*加权或SW成像上呈低信号灶,主要反映血管病所致含铁血黄素沉积。
- 1.5T或3.0T结合T2*或SW成像诊断CMBs真阳性率48%-89%,假阳性率11%-24%。
- 与尸检组织病理对照,生前临床MR至少漏诊半数CMBs。
核心结论
- CMBs是MR T2*加权或SW成像上的低信号灶,反映血管病所致含铁血黄素沉积;其检出率随场强、三维序列和相位后处理提高,但假阳性与漏诊不容忽视;CMBs见于正常老化及多种疾病,卒中患者合并CMBs提示预后更差,抗凝调整指南正在制定中。
研究设计与样本
- 综述,纳入MR影像表现与临床意义相关文献;参考标准为尸检组织病理分析,涉及1.5T或3.0T的T2*加权或SW成像。
关键影像表现/征象
- CMBs在T2*加权或SW成像上表现为低信号灶,主要源于局部磁敏感变化。
- CMBs的病理基础为血管病所致铁沉积,多见于血管周围巨噬细胞。
- 假阳性「模仿者」包括微夹层、微动脉瘤和微钙化,其中微钙化可用相位图鉴别。
诊断标准与关键数值
- 1.5T或3.0T结合T2*加权或SW成像诊断CMBs的真阳性率48%-89%,假阳性率11%-24%。
- 与尸检组织病理对照,生前临床MR至少漏诊半数CMBs。
临床应用与阅片要点
- CMBs检出率随场强提高、使用三维序列及利用MR相位局部扰动增强T2*对比的后处理方法而增加。
- 微钙化等假阳性「模仿者」可借助相位图与CMBs鉴别。
- CMBs见于正常老化,在阿尔茨海默痴呆、脑淀粉样血管病、卒中和创伤中更常见;罕见病因包括心内膜炎、常染色体显性遗传性脑动脉病伴皮质下梗死和白质脑病及放射治疗。
局限性
- 与尸检组织病理对照,生前临床MR至少漏诊半数CMBs。
- CMBs的假阳性「模仿者」发生率为11%-24%。
- 原文指出抗凝治疗调整指南仍在制定中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Cerebral microbleeds (CMBs), also referred to as microhemorrhages, appear on magnetic resonance (MR) images as hypointense foci notably at T2*-weighted or susceptibility-weighted (SW) imaging. CMBs are detected with increasing frequency because of the more widespread use of high magnetic field strength and of newer dedicated MR imaging techniques such as three-dimensional gradient-echo T2*-weighted and SW imaging. The imaging appearance of CMBs is mainly because of changes in local magnetic susceptibility and reflects the pathologic iron accumulation, most often in perivascular macrophages, because of vasculopathy. CMBs are depicted with a true-positive rate of 48%-89% at 1.5 T or 3.0 T and T2*-weighted or SW imaging across a wide range of diseases. False-positive "mimics" of CMBs occur at a rate of 11%-24% and include microdissections, microaneurysms, and microcalcifications; the latter can be differentiated by using phase images. Compared with postmortem histopathologic analysis, at least half of CMBs are missed with premortem clinical MR imaging. In general, CMB detection rate increases with field strength, with the use of three-dimensional sequences, and with postprocessing methods that use local perturbations of the MR phase to enhance T2* contrast. Because of the more widespread availability of high-field-strength MR imaging systems and growing use of SW imaging, CMBs are increasingly recognized in normal aging, and are even more common in various disorders such as Alzheimer dementia, cerebral amyloid angiopathy, stroke, and trauma. Rare causes include endocarditis, cerebral autosomal dominant arteriopathy with subcortical infarcts, leukoencephalopathy, and radiation therapy. The presence of CMBs in patients with stroke is increasingly recognized as a marker of worse outcome. Finally, guidelines for adjustment of anticoagulant therapy in patients with CMBs are under development. © RSNA, 2018.
引用
- Haller S, Vernooij MW, Kuijer JPA, et al. Cerebral Microbleeds: Imaging and Clinical Significance. Radiology. 2018. PMID: 29558307. doi:10.1148/radiol.2018170803
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。